Net profit/loss of H. Lundbeck 2009-2017
Annual net profit/loss of H. Lundbeck from 2009 to 2017 (in million DKK)
This statistic shows the net profit or loss of the Danish pharmaceutical company H. Lundbeck from 2009 to 2017. The net loss was down at the lowest value in 2015, with approximately minus 5.7 billion Danish kronor. The value peaked in 2017, at roughly 2.6 billion Danish kroner.
Annual net profit/loss of H. Lundbeck from 2009 to 2017 (in million DKK)
Source
More information
Statistics on "Pharmaceutical industry in Denmark "
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Average number of employees at LEO Pharma from 2007-2017
- Revenue of H. Lundbeck 2017, by product
- Operating profit/loss (EBIT) of H. Lundbeck 2009-2017
- Average number of employees at H. Lundbeck 2009-2017
- Revenue of LEO Pharma 2017, by region
- Operating profit/ loss (EBIT) of LEO Pharma from 2007-2017
- Operating profit (EBIT) of Recipharm 2007-2017
- Recordati: revenues 2018, by area
- Recordati: revenues' distribution 2018, by product
- Recordati: revenues' distribution 2018, by geographic area
- Bracco: revenue in 2016, by business unit
- Genomma Lab: total assets 2013-2018
- Recordati: worldwide net profit 2012-2017
- Genomma Lab: headcount 2015-2018
- Recordati: worldwide EBIT 2012-2017
- Net profits of Aurobindo Pharma Limited in India 2012-2018
- Terumo Corporation number of employees FY 2012-2017
- Revenue of Aurobindo Pharma Limited in India 2012-2018
- Genomma Lab: revenue 2017, by brand
- Disperse dyes: sales volume in the United Kingdom (UK) 2010-2017
Statistics on "Pharmaceutical industry in Denmark "
Related topics
About Statista
